Underrecognition and Suboptimal Quality of Care for Nonalcoholic Fatty Liver Disease Cirrhosis in Primary Care Patients with Diabetes Mellitus
Approximately 25-37% of the U.S. population has NAFLD, including up to 70% of adults with type 2 diabetes mellitus.1,2 About 30% of NAFLD patients have nonalcoholic steatohepatitis (NASH), of whom roughly 11% develop cirrhosis,3 resulting in an extraordinarily large NAFLD cirrhosis population. NASH is now the fastest growing etiology of cirrhosis and hepatocellular carcinoma among patients awaiting liver transplantation (LT).4,5 Nevertheless, both NAFLD and cirrhosis are underrecognized by primary care providers (PCPs).
Source: The American Journal of Medicine - Category: General Medicine Authors: JN Chu, ML Goldman, D Brandman, JH Sohn, K Islam, L Ross, RK Fox Tags: Brief Observation Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | General Medicine | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Non-alcoholic Fatty Liver Diseases (NAFLD) | Primary Care | Transplants | Urology & Nephrology